AWP
ABBV icon

Astra Wealth Partners’s AbbVie ABBV Stock Holding History

Astra Wealth Partners’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$234K Buy
+932
New +$201K 0.12% 94
2026
Q1 		– Sell
-897
Closed -$205K – 96
2025
Q4 		$205K Buy
+897
New +$204K 0.12% 96

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Astra Wealth Partners's ABBV Position: Q2 2026 in Review

Astra Wealth Partners opened a new position in AbbVie (ABBV) in Q2 2026: 932 shares worth $234K. The stake represents 0.12% of the portfolio and ranks #94 among its holdings. This is a return to the name: Astra Wealth Partners previously reported a position in ABBV as recently as Q4 2025.

Astra Wealth Partners first reported a position in ABBV in Q4 2025 and has held it in 2 quarters since. 4,215 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Astra Wealth Partners held 932 shares of AbbVie worth $234K as of Q2 2026.
  • AbbVie was a new Astra Wealth Partners position in Q2 2026.
  • AbbVie made up 0.12% of Astra Wealth Partners's portfolio in Q2 2026, its #94 holding.
  • Astra Wealth Partners first reported a position in AbbVie in Q4 2025 and has held it in 2 quarters since.
  • 4,215 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Astra Wealth Partners's 13F filing for Q2 2026, filed 11 Aug 2026.